Judge: Investors Failed To Properly Service Drug Company’s Director
NEWARK, N.J. — Dismissal of claims against a pharmaceutical company’s director in a securities class action lawsuit is proper because lead plaintiffs failed to serve the director within the statutorily required...To view the full article, register now.
Already a subscriber? Click here to view full article